LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: Freezing of gait in older people: associated conditions, clinical aspects, assessment and treatment.

    Thanvi, Bhomraj / Treadwell, Sean D

    Postgraduate medical journal

    2010  Volume 86, Issue 1018, Page(s) 472–477

    Abstract: Freezing of gait (FOG) is a disabling condition in older people. It is common in Parkinson's disease (PD) and other parkinsonian syndromes. The assessment of this condition poses challenges due to its episodic and transient nature and its frequent ... ...

    Abstract Freezing of gait (FOG) is a disabling condition in older people. It is common in Parkinson's disease (PD) and other parkinsonian syndromes. The assessment of this condition poses challenges due to its episodic and transient nature and its frequent association with cognitive impairment. The pathophysiology of FOG is complex and poorly understood. Morphological brain imaging is of limited value in the evaluation of FOG, and functional imaging techniques are currently being developed to study the phenomenon. The treatment of 'off' time FOG in PD is relatively straight forward, but 'on' freezing in PD and FOG associated with other conditions may be difficult to treat. FOG is a strong risk factor for falls and adversely affects the quality of life of patients and carers. A multidisciplinary team approach is essential for optimum management.
    MeSH term(s) Aged ; Dopamine Agents/therapeutic use ; Gait Disorders, Neurologic/etiology ; Gait Disorders, Neurologic/therapy ; Humans ; Neurodegenerative Diseases/complications ; Neurodegenerative Diseases/diagnosis ; Parkinson Disease/complications ; Parkinsonian Disorders/complications ; Patient Care Team
    Chemical Substances Dopamine Agents
    Language English
    Publishing date 2010-08
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/pgmj.2009.090456
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Malignant middle cerebral artery (MCA) infarction: pathophysiology, diagnosis and management.

    Treadwell, Sean D / Thanvi, Bhomraj

    Postgraduate medical journal

    2010  Volume 86, Issue 1014, Page(s) 235–242

    Abstract: Malignant MCA infarction' is the term used to describe rapid neurological deterioration due to the effects of space occupying cerebral oedema following middle cerebral artery (MCA) territory stroke. Early neurological decline and symptoms such as ... ...

    Abstract 'Malignant MCA infarction' is the term used to describe rapid neurological deterioration due to the effects of space occupying cerebral oedema following middle cerebral artery (MCA) territory stroke. Early neurological decline and symptoms such as headache and vomiting should alert the clinician to this syndrome, supported by radiological evidence of cerebral oedema and mass effect in the context of large hemispheric infarction. The prognosis is generally poor, and death usually occurs as a result of transtentorial herniation and brainstem compression. Treatment options include general measures and pharmacological agents to limit the extent of oedema, and surgical decompression to relieve the pressure effects. Until recently there has been little evidence to guide appropriate treatment, though in the last few years randomised data have been published addressing the role of surgical decompression. A pooled analysis of three European randomised controlled trials suggests that hemicraniectomy performed within 48 h significantly reduces mortality, and improves functional outcome in selected patients, and this has been reflected in recent national guidelines.
    MeSH term(s) Brain Edema/prevention & control ; Decompression, Surgical/methods ; Humans ; Infarction, Middle Cerebral Artery/diagnosis ; Infarction, Middle Cerebral Artery/etiology ; Infarction, Middle Cerebral Artery/therapy ; Intracranial Hypertension/prevention & control ; Patient Positioning ; Stroke/prevention & control ; Tomography, Emission-Computed, Single-Photon ; Tomography, X-Ray Computed
    Language English
    Publishing date 2010-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/pgmj.2009.094292
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Complete occlusion of extracranial internal carotid artery: clinical features, pathophysiology, diagnosis and management.

    Thanvi, Bhomraj / Robinson, Tom

    Postgraduate medical journal

    2007  Volume 83, Issue 976, Page(s) 95–99

    Abstract: A complete occlusion of the internal carotid artery (ICA) is an important cause of cerebrovascular disease. A never-symptomatic ICA occlusion has a relatively benign course, whereas symptomatic occlusion increases future risk of strokes. Ultrasonography, ...

    Abstract A complete occlusion of the internal carotid artery (ICA) is an important cause of cerebrovascular disease. A never-symptomatic ICA occlusion has a relatively benign course, whereas symptomatic occlusion increases future risk of strokes. Ultrasonography, magnetic resonance imaging and contrast angiography are useful diagnostic tests, and functional imaging of the brain (eg, with positron emission tomography) helps to understand haemodynamic factors involved in the pathophysiology of brain ischaemia. Recently, there has been a resurgence of interest in the role of extracranial-intracranial bypass surgery for the treatment of completely occluded ICA. With advances in the measurement of cerebral haemodynamics, it may be possible to identify high-risk patients who could benefit from the bypass surgery.
    MeSH term(s) Anticoagulants/therapeutic use ; Brain Ischemia/etiology ; Carotid Artery, Internal ; Carotid Stenosis/diagnosis ; Carotid Stenosis/etiology ; Carotid Stenosis/therapy ; Cerebral Revascularization/methods ; Fibrinolytic Agents/therapeutic use ; Humans ; Ischemia/etiology ; Prognosis ; Retinal Vessels
    Chemical Substances Anticoagulants ; Fibrinolytic Agents
    Language English
    Publishing date 2007-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/pgmj.2006.048041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people.

    Thanvi, Bhomraj / Robinson, Tom

    Age and ageing

    2006  Volume 35, Issue 6, Page(s) 565–571

    Abstract: Cerebral amyloid angiopathy (CAA) is an important cause of primary intracerebral haemorrhage (PICH) in older people, accounting for approximately 10% of all types of PICH. The amount of amyloid deposition in the vessels and vasculopathic changes ... ...

    Abstract Cerebral amyloid angiopathy (CAA) is an important cause of primary intracerebral haemorrhage (PICH) in older people, accounting for approximately 10% of all types of PICH. The amount of amyloid deposition in the vessels and vasculopathic changes determine the propensity to PICH. The risk factors of CAA include advanced age and the presence of certain alleles of apolipoprotein E. There are no specific clinical features of CAA-related PICH, although lobar, recurrent or multiple simultaneous haemorrhages in older patients should raise suspicion of its diagnosis. A definitive diagnosis of CAA requires pathological examination of the affected tissue. However, with modern imaging techniques, it is possible to make a diagnosis of 'probable CAA' in patients presenting with PICH. Gradient-echo magnetic resonance imaging is a sensitive, non-invasive technique for identifying small haemorrhages in life. Currently, there is no specific treatment available for CAA. Recent advances in the immunopathology and pathogenesis of CAA are expected to help in developing specific anti-amyloid therapy.
    MeSH term(s) Aged ; Brain/blood supply ; Brain/pathology ; Cerebral Amyloid Angiopathy/complications ; Cerebral Amyloid Angiopathy/diagnosis ; Cerebral Amyloid Angiopathy/therapy ; Cerebral Hemorrhage/etiology ; Humans ; Prognosis ; Risk Factors
    Language English
    Publishing date 2006-11
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 186788-x
    ISSN 1468-2834 ; 0002-0729
    ISSN (online) 1468-2834
    ISSN 0002-0729
    DOI 10.1093/ageing/afl108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Reducing hospital bed use by frail older people: results from a systematic review of the literature.

    Philp, Ian / Mills, Karen A / Thanvi, Bhomraj / Ghosh, Kris / Long, Judith F

    International journal of integrated care

    2013  Volume 13, Page(s) e048

    Abstract: Introduction: Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay (LOS) amongst frail older people. In this study, we have undertaken a systematic ... ...

    Abstract Introduction: Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay (LOS) amongst frail older people. In this study, we have undertaken a systematic review of the recent international literature (2007-present) to help improve our understanding about the impact of these interventions.
    Methods: WE SYSTEMATICALLY SEARCHED THE FOLLOWING DATABASES: PubMed/Medline, PsycINFO, CINAHL, BioMed Central and Kings Fund library. Studies were limited to publications from the period 2007-present and a total of 514 studies were identified.
    Results: A total of 48 studies were included for full review consisting of 11 meta-analyses, 9 systematic reviews, 5 structured literature reviews, 8 randomised controlled trials and 15 other studies. We classified interventions into those which aimed to prevent admission, interventions in hospital, and those which aimed to support early discharge.
    Conclusions: Reducing unnecessary use of acute hospital beds by older people requires an integrated approach across hospital and community settings. A stronger evidence base has emerged in recent years about a broad range of interventions which may be effective. Local agencies need to work together to implement these interventions to create a sustainable health care system for older people.
    Language English
    Publishing date 2013-12-05
    Publishing country England
    Document type Journal Article
    ISSN 1568-4156
    ISSN 1568-4156
    DOI 10.5334/ijic.1148
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Reducing hospital bed use by frail older people

    Ian Philp / Karen Anne Mills / Judith F Long / Bhomraj Thanvi / Kris Ghosh

    International Journal of Integrated Care, Vol 13, Iss

    results from a systematic review of the literature

    2013  Volume 4

    Abstract: Introduction Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay amongst frail older people. In this study we have undertaken a systematic review of ... ...

    Abstract Introduction Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay amongst frail older people. In this study we have undertaken a systematic review of the recent international literature (2007-present) to help improve our understanding about the impact of these interventions. Methods We systematically searched the following databases: PubMed / Medline, PsycINFO, CINAHL, BioMed Central, Kings Fund library. Studies were limited to publications from the period 2007-present and a total of 514 studies were identified. Results A total of 48 studies were included for full review consisting of 11 meta-analyses, 9 systematic reviews, 5 structured literature reviews, 8 randomised controlled trials and 15 other studies. We classified interventions into those which aimed to prevent admission, interventions in hospital, and those which aimed to support early discharge. Conclusions Reducing unnecessary use of acute hospital beds by older people requires an integrated approach across hospital and community settings. A stronger evidence base has emerged in recent years about a broad range of interventions which may be effective. Local agencies need to work together to implement these interventions to create a sustainable healthcare system for older people.
    Keywords older people ; hospital bed use ; admissions avoidance ; Medicine (General) ; R5-920
    Subject code 360
    Language English
    Publishing date 2013-12-01T00:00:00Z
    Publisher Ubiquity Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Reducing hospital bed use by frail older people

    Ian Philp / Karen Anne Mills / Judith F Long / Bhomraj Thanvi / Kris Ghosh

    International Journal of Integrated Care, Vol 13, Iss

    results from a systematic review of the literature

    2013  Volume 4

    Abstract: Introduction Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay amongst frail older people. In this study we have undertaken a systematic review of ... ...

    Abstract Introduction Numerous studies have been conducted in developed countries to evaluate the impact of interventions designed to reduce hospital admissions or length of stay amongst frail older people. In this study we have undertaken a systematic review of the recent international literature (2007-present) to help improve our understanding about the impact of these interventions. Methods We systematically searched the following databases: PubMed / Medline, PsycINFO, CINAHL, BioMed Central, Kings Fund library. Studies were limited to publications from the period 2007-present and a total of 514 studies were identified. Results A total of 48 studies were included for full review consisting of 11 meta-analyses, 9 systematic reviews, 5 structured literature reviews, 8 randomised controlled trials and 15 other studies. We classified interventions into those which aimed to prevent admission, interventions in hospital, and those which aimed to support early discharge. Conclusions Reducing unnecessary use of acute hospital beds by older people requires an integrated approach across hospital and community settings. A stronger evidence base has emerged in recent years about a broad range of interventions which may be effective. Local agencies need to work together to implement these interventions to create a sustainable healthcare system for older people.
    Keywords older people ; hospital bed use ; admissions avoidance ; Medicine (General) ; R5-920
    Subject code 360
    Language English
    Publishing date 2013-12-01T00:00:00Z
    Publisher Ubiquity Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.

    Thanvi, Bhomraj / Lo, Nelson / Robinson, Tom

    Postgraduate medical journal

    2007  Volume 83, Issue 980, Page(s) 384–388

    Abstract: Levodopa is the most effective drug for treating Parkinson's disease. However, long-term use of levodopa is often complicated by significantly disabling fluctuations and dyskinesias negating its beneficial effects. Younger age of Parkinson's disease ... ...

    Abstract Levodopa is the most effective drug for treating Parkinson's disease. However, long-term use of levodopa is often complicated by significantly disabling fluctuations and dyskinesias negating its beneficial effects. Younger age of Parkinson's disease onset, disease severity, and high levodopa dose increase the risk of development of levodopa-induced dyskinesias (LID). The underlying mechanisms for LID are unclear though recent studies indicate the importance of pulsatile stimulation of striatal postsynaptic receptors in their pathogenesis. The non-human primates with MPTP-induced parkinsonism serve as a useful model to study dyskinesia. Once established, LID are difficult to treat and therefore efforts should be made to prevent them. The therapeutic and preventative strategies for LID include using a lower dosage of levodopa, employing dopamine agonists as initial therapy in Parkinson's disease, amantadine, atypical neuroleptics, and neurosurgery. LID can adversely affect the quality of life and increase the cost of healthcare.
    MeSH term(s) Antiparkinson Agents/adverse effects ; Dopamine Agents/adverse effects ; Dyskinesia, Drug-Induced/etiology ; Dyskinesia, Drug-Induced/prevention & control ; Dyskinesia, Drug-Induced/therapy ; Humans ; Levodopa/adverse effects ; Neurosurgical Procedures/methods ; Parkinson Disease/complications ; Receptors, N-Methyl-D-Aspartate/drug effects ; Risk Factors
    Chemical Substances Antiparkinson Agents ; Dopamine Agents ; Receptors, N-Methyl-D-Aspartate ; Levodopa (46627O600J)
    Language English
    Publishing date 2007-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80325-x
    ISSN 1469-0756 ; 0032-5473
    ISSN (online) 1469-0756
    ISSN 0032-5473
    DOI 10.1136/pgmj.2006.054759
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Essential tremor-the most common movement disorder in older people.

    Thanvi, Bhomraj / Lo, Nelson / Robinson, Tom

    Age and ageing

    2006  Volume 35, Issue 4, Page(s) 344–349

    Abstract: Essential tremor (ET) affects approximately 4% of the population above 65 years of age. The traditional view that ET is a familial monosymptomatic disorder with a benign prognosis has recently been challenged, as it is now known to be a progressive and ... ...

    Abstract Essential tremor (ET) affects approximately 4% of the population above 65 years of age. The traditional view that ET is a familial monosymptomatic disorder with a benign prognosis has recently been challenged, as it is now known to be a progressive and clinically heterogeneous condition with sporadic and familial forms. The pathogenesis of ET is not fully understood, though a disordered central mechanism is the most likely site of origin with possible modulation by muscle adrenoreceptors. The limited post-mortem studies have not shown consistent abnormalities in the brains of ET patients. ET is often misdiagnosed as Parkinson's disease, particularly in the older population. Tremor amplitude increases with age, accounting for substantial disability in older people. Current therapy (drugs and neurosurgery) has significant limitations in older people. A better understanding of its pathophysiology in the future will help in developing more effective therapy, including neuroprotective strategies.
    MeSH term(s) Adrenergic beta-Antagonists/therapeutic use ; Aged ; Anti-Dyskinesia Agents/therapeutic use ; Anticonvulsants/therapeutic use ; Benzodiazepines/therapeutic use ; Botulinum Toxins/therapeutic use ; Carbonic Anhydrase Inhibitors/therapeutic use ; Diagnosis, Differential ; Dopamine Plasma Membrane Transport Proteins ; Essential Tremor/diagnosis ; Essential Tremor/epidemiology ; Essential Tremor/etiology ; Essential Tremor/therapy ; Humans ; Primidone/therapeutic use
    Chemical Substances Adrenergic beta-Antagonists ; Anti-Dyskinesia Agents ; Anticonvulsants ; Carbonic Anhydrase Inhibitors ; Dopamine Plasma Membrane Transport Proteins ; Benzodiazepines (12794-10-4) ; Primidone (13AFD7670Q) ; Botulinum Toxins (EC 3.4.24.69)
    Language English
    Publishing date 2006-07
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 186788-x
    ISSN 1468-2834 ; 0002-0729
    ISSN (online) 1468-2834
    ISSN 0002-0729
    DOI 10.1093/ageing/afj072
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Vascular parkinsonism--an important cause of parkinsonism in older people.

    Thanvi, Bhomraj / Lo, Nelson / Robinson, Tom

    Age and ageing

    2005  Volume 34, Issue 2, Page(s) 114–119

    Abstract: Parkinsonism due to cerebrovascular disease (vascular parkinsonism, VP) is a distinct clinicopathological entity. It accounts for 4.4-12% of all cases of parkinsonism. Since there are no specific diagnostic criteria, true incidence and prevalence rates ... ...

    Abstract Parkinsonism due to cerebrovascular disease (vascular parkinsonism, VP) is a distinct clinicopathological entity. It accounts for 4.4-12% of all cases of parkinsonism. Since there are no specific diagnostic criteria, true incidence and prevalence rates of VP are not known. Typically, parkinsonism in slow-onset VP tends to be bilaterally symmetrical, affecting the lower limbs more than the upper limbs ('lower-body parkinsonism'), and resting tremor is usually absent. Commonly noted lesions on brain imaging in VP are lacunes, white matter changes and, rarely, territorial infarcts. As coincidental vascular lesions in idiopathic Parkinson's disease (PD) are common, the mere presence of these lesions on brain imaging is not diagnostic of VP. Pathological evidence of a vascular disease in the absence of typical PD lesions (e.g. Lewy bodies) is the diagnostic 'gold standard'. VP is generally considered to be poorly or non-responsive to L-dopa therapy. However, recent studies have shown a beneficial effect of L-dopa in a subset of patients. Despite great advances in overall understanding of the disease, there are several gaps in our knowledge.
    MeSH term(s) Aged ; Antiparkinson Agents/therapeutic use ; Brain/drug effects ; Brain/pathology ; Cerebral Infarction/complications ; Cerebral Infarction/diagnosis ; Diagnostic Imaging ; Humans ; Intracranial Arteriosclerosis/complications ; Intracranial Arteriosclerosis/diagnosis ; Levodopa/therapeutic use ; Neurologic Examination ; Parkinson Disease/diagnosis ; Parkinson Disease, Secondary/diagnosis ; Parkinson Disease, Secondary/drug therapy ; Risk Factors ; Treatment Outcome
    Chemical Substances Antiparkinson Agents ; Levodopa (46627O600J)
    Language English
    Publishing date 2005-03
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 186788-x
    ISSN 1468-2834 ; 0002-0729
    ISSN (online) 1468-2834
    ISSN 0002-0729
    DOI 10.1093/ageing/afi025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top